A carregar...
Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review
RATIONALE: Nivolumab is a monoclonal IgG antibody blocking programmed death receptor-1 (PD1), leading to restoration of the natural T-cell-mediated immune response against the cancer cells. However, it also causes plenty of autoimmune-related adverse events, which often involves endocrine system. PA...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5682799/ https://ncbi.nlm.nih.gov/pubmed/29095280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000008426 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|